Kneat Com (KSIOF) Stock News

Kneat (OTC: KSIOF), a company specializing in digitizing and automating validation and quality processes, has scheduled its Q2 2025 financial results release for August 5, 2025 after TSX market close.

The company will host a conference call and Q&A session for analysts on August 6, 2025 at 09:00 ET. CEO Eddie Ryan and CFO Dave O'Reilly, along with outgoing CFO Hugh Kavanagh, will lead the webcast presentation. The financial results will be accessible through the company's investor relations website.

Kneat (OTCQC: KSIOF), a leader in digitizing and automating validation and quality processes, has announced a significant leadership transition. CFO Hugh Kavanagh will retire from the company, with his final day set for August 8th, 2025.

The company has appointed Dave O'Reilly as the new CFO, effective July 7th, 2025. O'Reilly brings substantial experience from his previous role as CFO at Ekco, where he helped scale the company to $200 million in annual revenue. His background includes serving as international controller for a $4 billion-SaaS business, Consensus Cloud Solutions/Ziff Davis Inc.

To ensure continuity, Kavanagh and O'Reilly will work together for a one-month transition period. CEO Eddie Ryan expressed confidence in O'Reilly's ability to contribute to Kneat's continued scaling efforts in the Life Sciences sector.

Kneat (OTCQC: KSIOF) has secured a multi-year Master Services Agreement with a major U.S.-based healthcare technology and diagnostics company. The unnamed company, which employs over 50,000 people and operates manufacturing facilities in more than a dozen countries, will implement Kneat's Gx platform to digitize their Commissioning, Qualification and Validation workflows.

The platform will be deployed at several lead manufacturing sites, focusing on facilities, equipment, and computer systems validation. According to the State of Validation 2025 study, 93% of organizations are now using or planning to use digital validation, up from 86% in 2024.

Kneat (TSX: KSI) (OTC: KSIOF), a company specializing in digitizing and automating validation processes, held its Annual General Meeting (AGM) on May 28, 2025. At the meeting, shareholders voted on two main items: the election of directors and the re-appointment of auditors.

All five nominated directors were successfully elected to the board with strong approval ratings ranging from 96.02% to 100%. Edmund Ryan received unanimous support (100%), while Carol Leaman (99.97%), Nutan Behki (97.32%), Ian Ainsworth (97.27%), and Wade K. Dawe (96.02%) also received overwhelming approval.

Additionally, shareholders approved the re-appointment of KPMG LLP as the company's auditors with 99.91% of votes in favor.

Kneat.com (TSX: KSI, OTCQC: KSIOF) has secured a three-year Master Services Agreement with a major US-based clinical diagnostics manufacturer. The unnamed customer operates in over 40 countries with 14,000+ employees and is part of a larger life sciences organization employing more than 60,000 people. The agreement focuses on digitizing the customer's equipment validation process using Kneat's Gx platform. The client specializes in providing diagnostic solutions to hospitals, laboratories, and physicians' offices globally. This partnership aligns with the broader industry trend of life sciences companies transitioning from manual, paper-based validation processes to digital solutions for improved quality, compliance, and market efficiency.

Kneat (KSIOF) reported strong financial results for Q1 2025, with total revenue reaching $14.7 million, up 37% year-over-year. The company's SaaS revenue grew 42% to $13.8 million, while Annual Recurring Revenue (ARR) increased 51% to $63.5 million. Gross profit rose 38% to $10.9 million, maintaining a steady gross margin of 74%. The company showed significant improvement in profitability with EBITDA of $5.9 million compared to -$0.5 million in Q1 2024, and Adjusted EBITDA of $2.3 million versus $0.6 million. During Q1, Kneat announced several key developments, including a partnership with Capgemini and new client acquisitions in therapeutics, consumer products, and pharmaceuticals. The company also expanded its executive team, appointing a new Chief Innovation Officer and Chief Product Officer.

Kneat (TSX: KSI, OTC: KSIOF), a leader in validation and quality process digitization, announced key executive changes. Co-founder Kevin Fitzgerald will transition from Chief Product Officer to the newly created role of Chief Innovation Officer in early June, focusing on strategic vision and product innovation. He will not seek re-election to the Board of Directors. Donal O'Sullivan will join as the new Chief Product Officer, bringing over 25 years of software development leadership experience. O'Sullivan joins from My Compliance Office where he served as CPO, and previously held positions at PICO Ltd as Global Head of Analytics Product Management and at Corvil for 18 years in various product management roles.

Kneat, a leader in validation and quality process digitization, will release its Q1 2025 financial results on May 7, 2025, after TSX market close. The company has scheduled a conference call and Q&A session for sell-side analysts on May 8, 2025, at 09:00 ET (14:00 GMT).

Key details:

• Earnings Release Date: May 7, 2025 (post-market)
• Conference Call Date: May 8, 2025
• Time: 09:00 ET / 14:00 GMT
• Presenters: Eddie Ryan (CEO) and Hugh Kavanagh (CFO)

Investors can access the financial results through the Financial Information section on Kneat's website. A registration link is available for the live webcast of the analyst call.

Kneat (KSIOF) has secured a Services Agreement with a major European-based multinational generic pharmaceuticals manufacturer to digitalize its drawing management process. The unnamed client, with over 20,000 employees and operations in more than 100 countries, will initially implement Kneat's platform at its largest European manufacturing facility.

The drawing management system will support engineering and validation processes by digitalizing technical drawings, eliminating paper-based errors, maintaining revision traceability, and controlling access. The client has the potential to expand Kneat's usage to streamline all validation workflows across their operations.

Kneat reports strong performance metrics, including a 151% net revenue retention rate as of December 31, 2024, and a 97% customer satisfaction rate rating their support as 'very good' or 'excellent'. The company serves the majority of the top 20 largest life sciences companies globally.